MedTrace Logo

Novel Therapy for Glucose Intolerance in HIV Disease

NCT02006914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2013-12-10

No results posted yet for this study

Summary

This research is to investigate the nutritional supplement chromium picolinate. The investigators are testing to see how effective this supplement is in treating insulin resistance associated with HIV disease.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chromium Picolinate

Subjects will be asked to take chromium picolinate; 2 tablets per day, 1000 mcg or a placebo for a total of 8 weeks.

Sponsors & Collaborators

Principal Investigators

  • Marie C Gelato, MD, PhD · Stony Brook University School of Medicine Dept. Of Medicine/Endocrinology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2010-05-31
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02006914 on ClinicalTrials.gov